You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 |
|---|---|
| Biological Origin | Human |
| Target | SOST |
| Reactivity | Human |
| Tag | N-6×His |
| Expression Region | Gln 24 - Tyr 213 |
| Endotoxins | 1.0 EU per μg |
| Conjugation | Unconjugated |
| MW | 22.3 kDa |
| Purity | 90% |
| Protein Sequence | AAI01087.1 |
Storage & Handling
−| Storage | -20°C to -70°C for 12 months in lyophilized state;. -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower |
|---|---|
| Form/Appearance | Powder |
| Buffer/Preservatives | PBS, pH 7.4 |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Human SOST Protein, His Tag [orb2697844]
> 95%, determined by SDS-PAGE
This protein contains the mature form of human SOST (NP_0795131) (Gln 24-Tyr 213) was fused with a polyhistidine tag at the N-terminus and expressed from HEK293 Cells.
1 mg, 100 μgHuman SOST Protein, His Tag [orb2701397]
> 90%, determined by SDS-PAGE
This protein contains the mature form of human SOST (NP_0795131) (Gln 24-Tyr 213) was fused with a polyhistidine tag at the N-terminus and expressed from HEK293 Cells.
50 μg, 20 μgSOST Protein, Human, Recombinant (His), Biotinylated [orb1954684]
98.00%
22.5 kDa (predicted)
100 μg, 20 μgSOST Protein, Human, Recombinant (His & Avi), Biotinylated [orb1960775]
98.00%
24.2 kDa (predicted). Due to glycosylation,the protein migrates to 28-40 kDa based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
UniProt Details
−NCBI Reference Sequences
−| RefSeq | AAI01087.1 |
|---|
Protocol Information
Wu, Y. et al. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling Eur Rev Med Pharmacol Sci, 21, 470-478 (2017)

